PubRank
Search
About
Justyna Siwy
Author PubWeight™ 16.57
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis.
Hepatology
2011
1.28
2
Urinary proteomics for prediction of preeclampsia.
Hypertension
2011
1.20
3
Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric study.
PLoS One
2013
1.12
4
Comprehensive human urine standards for comparability and standardization in clinical proteome analysis.
Proteomics Clin Appl
2010
1.12
5
Long term metabolic syndrome induced by a high fat high fructose diet leads to minimal renal injury in C57BL/6 mice.
PLoS One
2013
0.90
6
Urinary collagen fragments are significantly altered in diabetes: a link to pathophysiology.
PLoS One
2010
0.89
7
CKD273, a new proteomics classifier assessing CKD and its prognosis.
PLoS One
2013
0.88
8
Fetal urinary peptides to predict postnatal outcome of renal disease in fetuses with posterior urethral valves (PUV).
Sci Transl Med
2013
0.87
9
Proteomic candidate biomarkers of drug-induced nephrotoxicity in the rat.
PLoS One
2012
0.82
10
Seminal plasma as a source of prostate cancer peptide biomarker candidates for detection of indolent and advanced disease.
PLoS One
2013
0.82
11
Urinary proteomics in obstructive sleep apnoea and obesity.
Eur J Clin Invest
2014
0.80
12
Impact of a 6-wk olive oil supplementation in healthy adults on urinary proteomic biomarkers of coronary artery disease, chronic kidney disease, and diabetes (types 1 and 2): a randomized, parallel, controlled, double-blind study.
Am J Clin Nutr
2014
0.78
13
High-resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS.
Methods Mol Biol
2013
0.77
14
Capillary electrophoresis interfaced with a mass spectrometer (CE-MS): technical considerations and applicability for biomarker studies in animals.
Curr Protein Pept Sci
2014
0.77
15
Urinary proteome analysis at 5-year followup of patients with nonoperated ureteropelvic junction obstruction suggests ongoing kidney remodeling.
J Urol
2012
0.77
16
Improving peptide relative quantification in MALDI-TOF MS for biomarker assessment.
Proteomics
2013
0.76
17
Proteomics as a Quality Control Tool of Pharmaceutical Probiotic Bacterial Lysate Products.
PLoS One
2013
0.75
18
A distinct urinary biomarker pattern characteristic of female Fabry patients that mirrors response to enzyme replacement therapy.
PLoS One
2011
0.75
19
Performance of different separation methods interfaced in the same MS-reflection TOF detector: a comparison of performance between CE versus HPLC for biomarker analysis.
Electrophoresis
2012
0.75